Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
Morabito F, Tripepi G, Mauro FR, Laurenti L, Reda G, Moia R, Condoluci A, Vincelli I, Chiarenza A, Vigna E, Martino EA, Bruzzese A, Mezzatesta S, Laureana R, Cutrona G, Di Raimondo F, Fronza G, Zucchetto A, Bomben R, Rossi FM, Olivieri J, Zaja F, Rossi D, Gaidano G, Del Principe MI, Ilariucci F, Del Poeta G, Ferrarini M, Neri A, Gattei V, Gentile M. Morabito F, et al. Among authors: rossi fm, rossi d. Am J Hematol. 2023 Jul;98(7):E157-E160. doi: 10.1002/ajh.26927. Epub 2023 Apr 17. Am J Hematol. 2023. PMID: 37067157 No abstract available.
[Ergonomic approach to risk control].
Alberti M, Rossi D. Alberti M, et al. Among authors: rossi d. G Ital Med Lav Ergon. 2001 Apr-Jun;23(2):172-80. G Ital Med Lav Ergon. 2001. PMID: 11505779 Italian.
Insight into microbiological control potential of pathogens in a veterinary hospital.
Dumont CF, Martins Ferreira AL, Mendes Dos Santos RL, de Jesus E Silva B, Martins Costa LR, Zanzarini Delfiol DJ, Rossi DA, Torres de Melo R. Dumont CF, et al. Among authors: rossi da. J Hosp Infect. 2024 May 16:S0195-6701(24)00170-1. doi: 10.1016/j.jhin.2024.05.002. Online ahead of print. J Hosp Infect. 2024. PMID: 38762099 No abstract available.
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.
Malcikova J, Pavlova S, Baliakas P, Chatzikonstantinou T, Tausch E, Catherwood M, Rossi D, Soussi T, Tichy B, Kater AP, Niemann CU, Davi F, Gaidano G, Stilgenbauer S, Rosenquist R, Stamatopoulos K, Ghia P, Pospisilova S. Malcikova J, et al. Among authors: rossi d. Leukemia. 2024 May 16. doi: 10.1038/s41375-024-02267-x. Online ahead of print. Leukemia. 2024. PMID: 38755420 Review.
Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence as single agent and in combination therapy.
Tarantelli C, Wald D, Munz N, Spriano F, Bruscaggin A, Cannas E, Cascione L, Gaudio E, Arribas AJ, Manjappa S, Golino G, Scalise L, Cacciapuoti MT, Zucca E, Stathis A, Inghirami G, Van Berkel PH, Rossi D, Caimi PF, Zammarchi F, Bertoni F. Tarantelli C, et al. Among authors: rossi d. Haematologica. 2024 May 9. doi: 10.3324/haematol.2023.284197. Online ahead of print. Haematologica. 2024. PMID: 38721745 Free article.
Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years.
Leclercq L, Bastide C, Lechevallier E, Walz J, Charvet AL, Gondran-Tellier B, Campagna J, Savoie PH, Long-Depaquit T, Daniel L, Rossi D, Pignot G, Baboudjian M. Leclercq L, et al. Among authors: rossi d. Fr J Urol. 2024 Mar;34(2):102571. doi: 10.1016/j.fjurol.2024.102571. Epub 2024 Feb 4. Fr J Urol. 2024. PMID: 38717459
1,714 results